Fundraising Fox

GenomOncology

Cleveland, US · Founded 2012 · Ohio LLC · 51 employees on LinkedIn · 1 known investors

Find your way into GenomOncology

44 people in our graph share verified history with the GenomOncology team — schools, employers, funds. One of them is your warm intro.

Sara Risch, PhDunlockedknows Justin Yeakley · together at Kent State University (overlapped)
×2knows the team · via Rosetta
×9knows the team · via Kent State University

GenomOncology builds precision oncology software, including its Precision Oncology Platform (POP) and a Pathology Workbench, along with content and curation data products for clinical genomics. It serves clinicians and researchers in cancer care through healthcare IT and bioinformatics tools.

AI & Machine LearningBiotechDigital HealthHealthtechSaaS

Founders & leadership

JYJustin Yeakley
Justin YeakleyinChief Information Security Officer & SVP, Product DevelopmentJustin Yeakley has held engineering and leadership roles in healthcare IT for over 20 years, including 13+ years at GenomOncology, where he progressed from Director of Application Development to SVP of Product Development and Chief Information Security Officer. He holds a degree in Computer Information Systems from Kent State University and certifications in HIPAA compliance and cybersecurity architecture, with expertise in clinical genomics platforms, FHIR/mCODE data pipelines, and AI applications in precision oncology.
LP
Len PagonNamed on SEC filing
JS
Jeff SmithNamed on SEC filing
JS
Jonathan SeatonNamed on SEC filing
BL
Brian LadenNamed on SEC filing
LZ
Lee ZapisNamed on SEC filing
BW
Brad WertzNamed on SEC filing

Investors · 1

Relevance VenturesBrentwood · $250K – $2.5M

Reported raises · per SEC filings

Form D private placements

$4.6M disclosed across 2 rounds · 2019–2020

▶$3.2MraisedApr 2020 · 10 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Jonathan SeatonDirector
  • Brian LadenDirector
  • Len PagonDirector
  • Jeff SmithExecutive Officer
  • Brad WertzExecutive Officer, Director
  • Lee ZapisDirector
Offering amount
$4.2M
Amount sold
$3.2M
First sale
Apr 2020
Incorporated
Limited Liability Company, Ohio
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.4MraisedNov 2019 · 13 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Len PagonDirector
  • Jeff SmithExecutive Officer
  • Jonathan SeatonDirector
  • Brian LadenDirector
  • Lee ZapisDirector
  • Brad WertzExecutive Officer, Director
Offering amount
$1.8M
Amount sold
$1.4M
First sale
Nov 2019
Incorporated
Limited Liability Company, Ohio
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 2

by search overlap
IDbyDNA64 shared keywordsScalable, high throughput DNA sequencing platforms.
Labcorp33 shared keywordsLabCorp provides diagnostic testing services and clinical trial recruitment solutions that connect patient insights to drug development for healthcare providers.

Companies competing with GenomOncology for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

GenomOncology Receives Investment from TriStar Technology Ventures - FinSMEsfinsmes.com · Feb 2014JumpStart Invests $250,000 in GenomOncology - BioSpacebiospace.com · Jun 2012

Frequently asked questions

What does GenomOncology do?
GenomOncology builds precision oncology software, including its Precision Oncology Platform (POP) and a Pathology Workbench, along with content and curation data products for clinical genomics. It serves clinicians and researchers in cancer care through healthcare IT and bioinformatics tools.
Who are GenomOncology's investors?
GenomOncology's investors include Relevance Ventures.
How much funding has GenomOncology raised?
GenomOncology has disclosed $4.6M raised across 2 rounds.
Where is GenomOncology headquartered?
GenomOncology is headquartered in Cleveland, US.